Antonijoan RM - Search Results

1

Gastrointestinal safety of triflusal solution in healthy volunteers: a proof of concept endoscopic study.

Antonijoan RM, Gich I, Azaro A, Sainz S, Balanzó J, Izquierdo I, Borja J, Donado E, Blanch I, Barbanoj MJ. Antonijoan RM, et al. Eur J Clin Pharmacol. 2011 Jul;67(7):663-9. doi: 10.1007/s00228-011-1004-9. Epub 2011 Feb 16. Eur J Clin Pharmacol. 2011. PMID: 21327422 Clinical Trial.

2

Bioavailability and pharmacokinetics of a new low molecular weight heparin (RO-11)--a three way cross-over study in healthy volunteers.

Falkon L, Sáenz-Campos D, Antonijoan R, Martín S, Barbanoj M, Fontcuberta J. Falkon L, et al. Thromb Res. 1995 Apr 1;78(1):77-86. doi: 10.1016/0049-3848(95)00036-4. Thromb Res. 1995. PMID: 7778068 Clinical Trial.

3

Levodopa does not aggravate postural tremor in Parkinson's disease.

Kulisevsky J, Avila A, Barbanoj M, Antonijoan R, Torres J, Arcelus R. Kulisevsky J, et al. Clin Neuropharmacol. 1995 Oct;18(5):435-42. doi: 10.1097/00002826-199510000-00006. Clin Neuropharmacol. 1995. PMID: 8665557

4

Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels.

Kulisevsky J, Avila A, Barbanoj M, Antonijoan R, Berthier ML, Gironell A. Kulisevsky J, et al. Brain. 1996 Dec;119 ( Pt 6):2121-32. doi: 10.1093/brain/119.6.2121. Brain. 1996. PMID: 9010015

5

Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency.

Barbanoj M, Antonijoan R, Morte A, Grinyó JM, Solà R, Vallès J, Peraire C, Cordero JA, Muñoz A, Jané F, Obach R. Barbanoj M, et al. Clin Pharmacol Ther. 1999 Nov;66(5):485-91. doi: 10.1016/S0009-9236(99)70011-1. Clin Pharmacol Ther. 1999. PMID: 10579475

6

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers.

Riba J, Rodríguez-Fornells A, Urbano G, Morte A, Antonijoan R, Montero M, Callaway JC, Barbanoj MJ. Riba J, et al. Psychopharmacology (Berl). 2001 Feb;154(1):85-95. doi: 10.1007/s002130000606. Psychopharmacology (Berl). 2001. PMID: 11292011 Clinical Trial.

7

Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.

Riba J, Rodríguez-Fornells A, Urbano G, Morte A, Antonijoan R, Barbanoj MJ. Riba J, et al. Psychopharmacology (Berl). 2001 Oct;157(4):358-67. doi: 10.1007/s002130100816. Psychopharmacology (Berl). 2001. PMID: 11605094 Clinical Trial.

8

A double-blind crossover, placebo-controlled study of the adenosine A2A antagonist theophylline in Parkinson's disease.

Kulisevsky J, Barbanoj M, Gironell A, Antonijoan R, Casas M, Pascual-Sedano B. Kulisevsky J, et al. Clin Neuropharmacol. 2002 Jan-Feb;25(1):25-31. doi: 10.1097/00002826-200201000-00005. Clin Neuropharmacol. 2002. PMID: 11852293 Clinical Trial.

9

Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.

Gispert J, Antonijoan R, Barbanoj M, Gich I, Garcia E, Esbrí R, Luria X. Gispert J, et al. Ann Allergy Asthma Immunol. 2002 Sep;89(3):259-64. doi: 10.1016/S1081-1206(10)61952-7. Ann Allergy Asthma Immunol. 2002. PMID: 12269645 Clinical Trial.

10

Evaluation of renal graft haemodynamia by 51Cr-EDTA and o-[131I]iodohippurate: its use in the early diagnosis of glomerular hyperfiltration.

Estorch M, Tembl A, Antonijoan R, Hernandez A, Mari C, Flotats A, Camacho V, Sola R, Barbanoj M, Carrio I. Estorch M, et al. Nucl Med Commun. 2003 Jun;24(6):679-82. doi: 10.1097/00006231-200306000-00010. Nucl Med Commun. 2003. PMID: 12766604 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters